Dual Antiretroviral Therapy—All Quiet Beneath the Surface?

by Berend J. van Welzen, Patrick G. A. Oomen, Andy I. M. Hoepelman
Published 2021-02-01

Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality

by Roos E. Barth, Hugo A. Tempelman, Robert Moraba, Andy I. M. Hoepelman
Published 2011-01-01

Within-host selection of drug resistance in a mouse model of repeated interrupted treatment of Plasmodium yoelii infection

by Suci Nuralitha, Josephine E. Siregar, Din Syafruddin, Andy I. M. Hoepelman, Sangkot Marzuki
Published 2017-05-01

Estimating regional prevalence of chronic hepatitis C with a capture-recapture analysis

by Patricia A. M. Kracht, Joop E. Arends, Andy I. M. Hoepelman, Mirjam E. E. Kretzschmar
Published 2021-07-01

The balancing perspective of hard-to-reach hepatitis C patients who were lost to follow-up: A qualitative study.

by Patricia A M Kracht, Joop E Arends, Andy I M Hoepelman, Sigrid C J M Vervoort
Published 2020-01-01

A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?

by Berend J. van Welzen, Tania Mudrikova, Ayman El Idrissi, Andy I. M. Hoepelman, Joop E. Arends
Published 2019-01-01

Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.

by Sabine M Hermans, Agnes N Kiragga, Petra Schaefer, Andrew Kambugu, Andy I M Hoepelman, Yukari C Manabe
Published 2010-05-01

Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa.

by G Emerens Wensink, Annelot F Schoffelen, Hugo A Tempelman, Maarten B Rookmaaker, Andy I M Hoepelman, Roos E Barth
Published 2015-01-01

Hepatitis B viral load and risk of HBV-related liver disease: from East to West?

by Soeradj Harkisoen, M.D., Joop E. Arends, Karel J. van Erpecum, Anneke van den Hoek, Andy I.M. Hoepelman
Published 2012-03-01

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)

by Thijs ten Doesschate, Suzan P. van Mens, Cees van Nieuwkoop, Suzanne E. Geerlings, Andy I. M. Hoepelman, Marc J. M. Bonten
Published 2018-12-01

Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.

by Annelot F Schoffelen, Annemarie M J Wensing, Hugo A Tempelman, Sibyl P M Geelen, Andy I M Hoepelman, Roos E Barth
Published 2013-01-01

Hospital Preparations for Viral Hemorrhagic Fever Patients and Experience Gained from Admission of an Ebola Patient

by J.J. Mark Haverkort, A.L.C. (Ben) Minderhoud, Jelte D.D. Wind, Luke P.H. Leenen, Andy I.M. Hoepelman, Pauline M. Ellerbroek
Published 2016-02-01

Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.

by Thijs Feuth, Joop E Arends, Justin H Fransen, Nening M Nanlohy, Karel J van Erpecum, Peter D Siersema, Andy I M Hoepelman, Debbie van Baarle
Published 2013-01-01

Introducing hepatitis C virus healthcare pathways in addiction care in the Netherlands with a Breakthrough project: a mixed method study

by Patricia A. M. Kracht, Elisabeth A. de Gee, Agnes van der Poel, Marc A. M. T. Verhagen, Andy I. M. Hoepelman, Esther A. Croes, Joop E. Arends
Published 2019-07-01

Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistance

by Axel Fun, Thomas Leitner, Linos Vandekerckhove, Martin Däumer, Alexander Thielen, Bernd Buchholz, Andy I. M. Hoepelman, Elizabeth H. Gisolf, Pauline J. Schipper, Annemarie M. J. Wensing, Monique Nijhuis
Published 2018-01-01

Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8+ T-Cell Subsets

by Ellen Veel, Liset Westera, Rogier van Gent, Louis Bont, Sigrid Otto, Bram Ruijsink, Huib H. Rabouw, Tania Mudrikova, Annemarie Wensing, Andy I. M. Hoepelman, José A. M. Borghans, Kiki Tesselaar
Published 2018-03-01

Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act

by Monique I Andersson, Ruma Rajbhandari, Michael C Kew, Sandro Vento, Wolfgang Preiser, Andy I M Hoepelman, Gerhard Theron, Mark Cotton, Jennifer Cohn, Dieter Glebe, Olufunmilayo Lesi, Mark Thursz, Marion Peters, Raymond Chung, Charles Wiysonge
Published 2015-07-01

Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates.

by Franky Baatz, Monique Nijhuis, Morgane Lemaire, Martiene Riedijk, Annemarie M J Wensing, Jean-Yves Servais, Petra M van Ham, Andy I M Hoepelman, Peter P Koopmans, Herman G Sprenger, Carole Devaux, Jean-Claude Schmit, Danielle Perez Bercoff
Published 2011-01-01

Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection

by Faydra I. Lieveld, Niels Swaans, Astrid M. Newsum, Cynthia K.Y. Ho, Janke Schinkel, Richard Molenkamp, Jan T.M. van der Meer, Joop E. Arends, Andy I.M. Hoepelman, Anne M.J. Wensing, Peter D. Siersema, Karel J. van Erpecum, Greet J. Boland
Published 2016-09-01

Identification of Risk Factors for Chronic Q Fever, the Netherlands

by Linda M. Kampschreur, Sandra Dekker, Julia C.J.P. Hagenaars, Peter J. Lestrade, Nicole H.M. Renders, Monique G.L. de Jager-Leclercq, Mirjam H.A. Hermans, Cornelis A.R. Groot, Rolf H.H. Groenwold, Andy I.M. Hoepelman, Peter C. Wever, Jan Jelrik Oosterheert
Published 2012-04-01